Press Releases
Filters
December 18, 2024
Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology
October 29, 2024
Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference
October 16, 2024
Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe
October 9, 2024
Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD)
October 8, 2024
Viatris Named to Forbes' Annual List of the World's Best Employers for the Fourth Year in a Row
September 17, 2024
Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer
Displaying 1 - 10 of 137